Prostat Kanserinde <sup>225</sup>Ac-PSMA-617 ve <sup>177</sup>Lu-PSMA-617’nin Subsellüler Dozimetriye Dayalı Göreceli Etkinliği
Author:
Publisher
Galenos Yayinevi
Subject
Radiology, Nuclear Medicine and imaging
Reference34 articles.
1. 2019, NCCN clinical practice guidelines in oncology;Mohler;J Natl Compr Canc Netw,2019
2. A systematic review and meta-analysis of the effectiveness and toxicities of lutetium-177-labeled Prostate-specific membrane antigen-targeted radioligand therapy in metastatic castration-resistant prostate cancer;Sadaghiani;Eur Urol,2021
3. Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls;Hofman;Radiographics,2018
4. Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer;Sartor;N Engl J Med,2021
5. );Hosono;Ann Nucl Med,2018
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Deescalated225Ac-PSMA-617 Versus177Lu/225Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 Patients;Journal of Nuclear Medicine;2024-06-06
2. Production study of Fr, Ra and Ac radioactive ion beams at ISOLDE, CERN;Scientific Reports;2024-05-14
3. Activity quantification and dosimetry in radiopharmaceutical therapy with reference to 177Lutetium;Frontiers in Nuclear Medicine;2024-03-28
4. PSMA Targeted Molecular Imaging and Radioligand Therapy for Prostate Cancer: Optimal Patient and Treatment Issues;Current Oncology;2023-08-01
5. Microdosimetric study of 177Lu and 225Ac combination therapy for mCRPC coupled with the mesh-type cell cluster model;2023-06-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3